TIBCS 2024 Channel – Insights into Immunotherapy and Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer

In this exclusive TIBCS 2024 interview, hosted by Dr. Yen-Jen Chen and Dr. Bo-Fang Chen from the Department of Surgery at Taipei Veterans General Hospital, renowned experts Dr. Sherene Loi and Dr. Tira Tan will explore the potential role of Tumor-Infiltrating Lymphocytes (TILs) in clinical practice and their influence on chemotherapy decisions, especially in triple-negative breast cancer. They will also discuss the current status and future prospects of immunotherapy, including its application in post-neoadjuvant settings and its integration with biomarkers. Don’t miss this engaging discussion on the latest innovations and challenges in personalized breast cancer treatment.